Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) Research Group

Research output: Contribution to journalShort surveypeer-review

44 Scopus citations
Original languageEnglish
Pages (from-to)316-319.e5
JournalGastroenterology
Volume162
Issue number1
DOIs
StatePublished - Jan 2022

Cite this